Robert Barnes

2.2k total citations
26 papers, 1.7k citations indexed

About

Robert Barnes is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Robert Barnes has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pharmacology and 7 papers in Psychiatry and Mental health. Recurrent topics in Robert Barnes's work include Treatment of Major Depression (6 papers), Cardiac Health and Mental Health (5 papers) and Stress Responses and Cortisol (4 papers). Robert Barnes is often cited by papers focused on Treatment of Major Depression (6 papers), Cardiac Health and Mental Health (5 papers) and Stress Responses and Cortisol (4 papers). Robert Barnes collaborates with scholars based in United States and Tanzania. Robert Barnes's co-authors include Murray A. Raskind, Richard C. Veith, Gail Gumbrecht, Jeffrey B. Halter, Steven C. Risse, Emily White, Pamela J. McLean, B. V. Reifler, Linda Teri and Marie-Ève Rivard and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Robert Barnes

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Barnes United States 19 794 373 280 268 248 26 1.7k
Damien Gallagher Canada 28 811 1.0× 225 0.6× 156 0.6× 272 1.0× 377 1.5× 80 2.2k
Beatrice Bortolato Brazil 13 1.1k 1.4× 286 0.8× 391 1.4× 432 1.6× 396 1.6× 15 2.7k
Eileen Brown United States 16 569 0.7× 218 0.6× 188 0.7× 545 2.0× 300 1.2× 31 2.0k
Mohammad Alsuwaidan Canada 22 881 1.1× 552 1.5× 147 0.5× 355 1.3× 266 1.1× 37 2.2k
Darryl Bassett Australia 21 1.0k 1.3× 565 1.5× 159 0.6× 571 2.1× 175 0.7× 52 2.1k
Tommi Tolmunen Finland 33 720 0.9× 292 0.8× 204 0.7× 732 2.7× 436 1.8× 108 2.9k
Dov Aizenberg Israel 29 1.7k 2.1× 357 1.0× 318 1.1× 721 2.7× 109 0.4× 95 2.7k
Hanan Munitz Israel 26 1.1k 1.4× 360 1.0× 419 1.5× 364 1.4× 190 0.8× 109 2.2k
John Potokar United Kingdom 27 418 0.5× 288 0.8× 120 0.4× 742 2.8× 110 0.4× 65 2.0k
Kurt Bjerregaard Stage Denmark 20 225 0.3× 277 0.7× 143 0.5× 192 0.7× 179 0.7× 39 1.1k

Countries citing papers authored by Robert Barnes

Since Specialization
Citations

This map shows the geographic impact of Robert Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Barnes more than expected).

Fields of papers citing papers by Robert Barnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Barnes. The network helps show where Robert Barnes may publish in the future.

Co-authorship network of co-authors of Robert Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Barnes. A scholar is included among the top collaborators of Robert Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Barnes. Robert Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnes, Robert, et al.. (2024). Propylene glycol toxicity in an adolescent secondary to chronic cornstarch ingestion. SHILAP Revista de lepidopterología. 5(3). e13188–e13188. 2 indexed citations
2.
Griffin, John D, Joanne Buxton, Jeffrey A. Culver, et al.. (2023). Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acids. Molecular Metabolism. 78. 101830–101830. 14 indexed citations
3.
Kesherwani, Varun, et al.. (2014). Fasudil reduces GFAP expression after hypoxic injury. Neuroscience Letters. 576. 45–50. 9 indexed citations
4.
Thompson, Charles E., Fletcher B. Taylor, Miles McFall, Robert Barnes, & Murray A. Raskind. (2008). Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: Response to prazosin. Journal of Traumatic Stress. 21(4). 417–420. 40 indexed citations
5.
Felker, Bradford, et al.. (2004). Preliminary Outcomes From an Integrated Mental Health Primary Care Team. Psychiatric Services. 55(4). 442–444. 35 indexed citations
6.
Felker, Bradford, Kevin L. Sloan, Jason A. Dominitz, & Robert Barnes. (2002). The Safety of Valproic Acid Use for Patients With Hepatitis C Infection. American Journal of Psychiatry. 160(1). 174–178. 23 indexed citations
7.
Teri, Linda, B. V. Reifler, Richard C. Veith, et al.. (1991). Imipramine in the Treatment of Depressed Alzheimer's Patients: Impact on Cognition. Journal of Gerontology. 46(6). P372–P377. 54 indexed citations
8.
Borson, Soo, Robert Barnes, Richard C. Veith, Jeffrey B. Halter, & Murray A. Raskind. (1989). Impaired Sympathetic Nervous System Response to Cognitive Effort in Early Alzheimer's Disease. Journal of Gerontology. 44(1). M8–M12. 34 indexed citations
9.
Reifler, B. V., Linda Teri, Murray A. Raskind, et al.. (1989). Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. American Journal of Psychiatry. 146(1). 45–49. 263 indexed citations
10.
Barnes, Robert, et al.. (1988). Quinine-induced thrombocytopenia. A case report.. PubMed. 70(7). 1097–9. 7 indexed citations
11.
Risse, Steven C. & Robert Barnes. (1986). Pharmacologic Treatment of Agitation Associated With Dementia. Journal of the American Geriatrics Society. 34(5). 368–376. 102 indexed citations
12.
Barnes, Robert, et al.. (1983). Medical illness in chronic psychiatric outpatients. General Hospital Psychiatry. 5(3). 191–195. 39 indexed citations
13.
Barnes, Robert, et al.. (1983). High levels of plasma catecholamines in dexamethasone-resistant depressed patients. American Journal of Psychiatry. 140(12). 1623–1625. 83 indexed citations
14.
Veith, Richard C., Murray A. Raskind, James H. Caldwell, et al.. (1982). Cardiovascular Effects of Tricyclic Antidepressants in Depressed Patients with Chronic Heart Disease. New England Journal of Medicine. 306(16). 954–959. 135 indexed citations
15.
Barnes, Robert, Murray A. Raskind, Gail Gumbrecht, & Jeffrey B. Halter. (1982). The Effects of Age on the Plasma Catecholamine Response to Mental Stress in Man*. The Journal of Clinical Endocrinology & Metabolism. 54(1). 64–69. 120 indexed citations
16.
Barnes, Robert, et al.. (1982). Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. American Journal of Psychiatry. 139(9). 1170–1174. 143 indexed citations
17.
Raskind, Murray A., Richard C. Veith, Robert Barnes, & Gail Gumbrecht. (1982). Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease. American Journal of Psychiatry. 139(9). 1114–1117. 18 indexed citations
18.
Barnes, Robert, Richard C. Veith, & Murray A. Raskind. (1981). Depression in older persons: diagnosis and management.. PubMed. 135(6). 463–8. 6 indexed citations
19.
Barnes, Robert & Murray A. Raskind. (1981). DSM-III Criteria and the Clinical Diagnosis of Dementia: A Nursing Home Study. Journal of Gerontology. 36(1). 20–27. 38 indexed citations
20.
Shenk, J. S., et al.. (1976). Relationship between β-Nitropropionic Acid Content of Crownvetch and Toxicity in Nonruminant Animals. Journal of Animal Science. 42(3). 616–621. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damien Gallagher Breakdown of academic impact, for papers by Beatrice Bortolato Breakdown of academic impact, for papers by Eileen Brown Breakdown of academic impact, for papers by Mohammad Alsuwaidan Breakdown of academic impact, for papers by Darryl Bassett Breakdown of academic impact, for papers by Tommi Tolmunen Breakdown of academic impact, for papers by Dov Aizenberg Breakdown of academic impact, for papers by Hanan Munitz Breakdown of academic impact, for papers by John Potokar Breakdown of academic impact, for papers by Kurt Bjerregaard Stage
Rankless by CCL
2026